By Karen Roman Medical tech company Nano-X Imaging Ltd. (Nasdaq: NNOX) said Nanox.ARC, its digital multi-source 3D ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and ...

PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S. New clinical data supporting use of Nanox ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition ...

Nanox Imaging Ltd. announced promising results from a clinical study showcasing its Nanox.ARC digital tomosynthesis system, which enhances musculoskeletal imaging and outperforms conventional ...

Nano-X Imaging shares were up 10%, to $6.61, after the company said it has received CE mark certification to market its multi-source Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud ...

So, for the shares of NanoX Imaging, a Zacks Rank of 2 is a more conclusive fundamental indication of a potential turnaround.